
CSL's Seqirus flu vaccine campaign keeps ‘twindemic’ danger of Covid-19 and seasonal flu on front burner
Is there a twindemic deja vu in the works? Although last year’s double whammy of Covid-19 and flu infections never panned out, CSL’s Seqirus wants to make sure it doesn’t happen this year, especially as flu cases are already on the rise.
As pandemic restrictions relax – more indoor meetups and travel and less mask wearing – the potential for a real twindemic is certainly possible. While reports of influenza are still lower than normal, cases are ramping up, according to the CDC’s Fluview monitoring system. The increase is happening, however, even as three in five people in the US say they plan to skip or delay a flu vaccine this season.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 158,600+ biopharma pros reading Endpoints daily — and it's free.